Target intelligence / Profile preview

Solute carrier transporters (Glucose and amino acid transporters) (SLC transporters)

Target
SLC transporters
Molecular classification
Transporter, Solute carrier family
01

Overview

Glucose and amino acid transporters are integral membrane proteins, primarily belonging to the Solute Carrier (SLC) superfamily, that facilitate the movement of essential nutrients across cellular membranes [1]. Glucose transporters include the facilitative GLUT (SLC2) family and the sodium-dependent SGLT (SLC5) family, which are critical for maintaining systemic glucose homeostasis and are major targets in the treatment of type 2 diabetes [2, 4]. Amino acid transporters, such as the Large Neutral Amino Acid Transporter 1 (LAT1/SLC7A5) and Sodium-coupled Neutral Amino Acid Transporters (SNATs/SLC38), regulate protein synthesis, neurotransmission, and metabolic signaling [3]. These transporters are frequently dysregulated in diseases; for instance, SGLT2 is targeted to reduce renal glucose reabsorption, while LAT1 is often overexpressed in various cancers to support rapid cell proliferation [5]. Therapeutic strategies include the use of small molecule inhibitors to block nutrient uptake in cancer or metabolic disease, as well as the design of prodrugs that exploit these transporters for improved bioavailability [1, 3]. Understanding the specific expression patterns and substrate specificities of these transporters is vital for developing targeted therapies and diagnostic tools [1].

Other names
Solute carrier familyGlucose transporterAmino acid transporterGLUTSGLTLATSNATSLC family
02

Mechanism of action

Inhibition of glucose reabsorption in the renal proximal tubule via SGLT2; competitive inhibition of large neutral amino acid transport via LAT1; utilization of transporters for the uptake of prodrugs or therapeutic substrates.

03

Biological functions

Nutrient transportMetabolic regulationHomeostasisCell growthSignal transduction
04

Disease associations

CancerDiabetesMetabolic disorderNeurological diseaseCardiovascular disease
05

Safety considerations

HypoglycemiaEuglycemic ketoacidosisUrinary tract infectionsElectrolyte imbalanceNutrient malabsorption
06

Interacting drugs

Canagliflozin

6 more in the full profile.

07

Biomarkers

Blood glucoseHbA1c18F-FDG PET imaging18F-FET PET imagingUrinary glucose excretion

Beyond the preview

Go deeper on Solute carrier transporters (Glucose and amino acid transporters) (SLC transporters).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier transporters (Glucose and amino acid transporters) (SLC transporters).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call